Ethical Performance
inside intelligence for responsible business


pharma forum to map out the future

June 2004

Pharmaceuticals companies, investors and stakeholders are being brought together to consider long term challenges to the industry, including how it can provide greater access to medicines for the poor.

Under the Pharmafutures project, supported by the UK’s Department for International Development, pension fund investors will take part in talks between drugs firms and their stakeholders to discuss ‘sustainable and advantageous business models’ for the sector.

Among topics to be considered are how companies can help improve access to drugs in developing countries, intellectual property protection, marketing, information and advertising, pricing, government health provision and demographic changes.

An initial workshop took place in May and another is scheduled for September.

Pharma Futures will also form a reference group of pharma sector specialists and sector analysts to predict where the pharmaceuticals market might be in 10 years time.

Funding for the project is provided jointly by DfiD, the Rockefeller Foundation and the Nathan Cummings Foundation. DfID believes it will inspire ‘blue skies thinking’ on social responsibility.

Pharma Futures is now a standalone project governed by three global pension funds – USS, ABP Investments and the Ohio Public Employees Retirement System – with support from a small secretariat managed by consultant Sophia Tickell.

3BL Media News
Sign up for Free e-news
Report Alerts
Job Vacancies
Events Updates
Best Practice Newsletter